Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
137.00    -8.00 (-5.52%)
Bid:
137.00
Ask:
140.00
Spread: 3.00 (2.19%)
Market Cap: £107.51m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Board changes

30 May 2024 12:00

RNS Number : 4436Q
Xaar PLC
30 May 2024
 

30 May 2024

 

Xaar plc

 

Board changes

 

Xaar plc ("Xaar" or "the Group" or "the Company"), the leading inkjet printing technology group, is pleased to announce the appointment of Dr Inken Braunschmidt as Independent Non-Executive Director.

 

Inken joins the Board with effect from 1 June 2024 and on appointment will be a member of the Audit, Remuneration and Nomination Committees.

 

As previously disclosed, Alison Littley had notified the Board of her intention to step down as a Non-Executive Director of the Company during 2024. It is now confirmed that Alison will leave the Board on 30 June 2024. Inken will be appointed as Chair of Remuneration Committee on 1 July 2024.

 

Richard Amos, Non-Executive Director, will replace Alison Littley as the Company's Senior Independent Director on 1 July 2024.

 

Inken Braunschmidt is currently a non-executive director of James Fisher and Sons plc, listed on the London Stock Exchange, and Chair of its Remuneration Committee as well as a member of the Audit and Nomination Committees. She was Chief Innovation and Digital Officer and member of the Executive Board of Halma plc until 2023. Prior to joining Halma plc in 2017, Inken spent 13 years at RWE AG, the German energy giant, and its renewables subsidiary innogy SE, where she held various international leadership roles focusing on strategy, innovation, digital transformation and change management. Inken studied Business Administration, Innovation & Technology Management at Kiel University and did her PhD thesis in Technology Management. Inken is member of the Digital Programme Board of the Royal Academy of Engineering.

 

 

Andrew Herbert, Chairman, commented:

 

"We are delighted to welcome Inken to the Board and her expertise and experience in international electronic engineering and digital innovation and transformation are very relevant to the opportunities and challenges that face Xaar. I would like to thank Alison for her contribution and commitment to the Board of Xaar as a director since 2020 and wish her the very best for the future."

 

The Company confirms there is no further information to be disclosed under the requirements of Listing Rule 9.6.13R in relation to the appointment of Inken Braunschmidt.

 

Enquiries:

 

Xaar plc

+44 (0) 1223 423 663 

Ian Tichias, Chief Financial Officer

John Mills, Chief Executive Officer

 

Teneo

Giles Kernick

Olivia Lucas

+44 (0) 207 353 4200

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAURAWRSAUVORR
Date   Source Headline
26th Apr 20063:56 pmRNSDirector/PDMR Shareholding
24th Apr 20064:29 pmRNSResult of AGM
24th Apr 20067:01 amRNSAGM positive trading update
18th Apr 20066:05 pmRNSDirector/PDMR Shareholding
18th Apr 200611:31 amRNSAnnual Information Update
5th Apr 20064:59 pmRNSDirector/PDMR Shareholding
30th Mar 20065:24 pmRNSHolding(s) in Company
14th Mar 20066:21 pmRNSDirector/PDMR Shareholding
14th Mar 20067:01 amRNSFinal Results
21st Feb 20067:01 amRNSNotice of Preliminary Results
14th Feb 20065:29 pmRNSHolding(s) in Company
12th Jan 20067:00 amRNSPeriod-end trading update
29th Nov 20057:00 amRNSHolding(s) in Company
25th Nov 20051:02 pmRNSDirector/PDMR Shareholding
23rd Nov 20055:43 pmRNSDirector/PDMR Shareholding
22nd Nov 20056:30 pmRNSDirector/PDMR Shareholding
7th Nov 20057:00 amRNSAnalyst and investor seminar
3rd Nov 20056:17 pmRNSHolding(s) in Company
24th Oct 20054:13 pmRNSDirector/PDMR Shareholding
24th Oct 20054:11 pmRNSDirector/PDMR Shareholding
24th Oct 20052:47 pmRNSHolding(s) in Company
14th Oct 20056:13 pmRNSHolding(s) in Company
14th Oct 20056:05 pmRNSHolding(s) in Company
12th Oct 200512:44 pmRNSDirector/PDMR Shareholding
10th Oct 20055:22 pmRNSDirector/PDMR Shareholding
6th Oct 20057:00 amRNSHolding(s) in Company
5th Oct 200510:59 amRNSDirector/PDMR Shareholding
27th Sep 20056:11 pmRNSDirector/PDMR Shareholding
20th Sep 20051:06 pmRNSDirector/PDMR Shareholding
14th Sep 20057:02 amRNSAppointment of director
14th Sep 20057:01 amRNSInterim Results
12th Sep 20057:00 amRNSInvestment in trade partner
16th Aug 20055:51 pmRNSNotice of Interim Results
16th Aug 20052:30 pmRNSNotice of Interim Results
28th Jul 20054:32 pmRNSHolding(s) in Company
21st Jul 200510:28 amRNSHolding(s) in Company
6th Jul 20057:00 amRNSPositive half year update
4th Jul 200511:36 amRNSHolding(s) in Company
4th Jul 200511:26 amRNSDirector/PDMR Shareholding
8th Jun 20056:31 pmRNSHolding(s) in Company
2nd Jun 20054:05 pmRNSHolding(s) in Company
26th May 20054:22 pmRNSHolding(s) in Company
26th May 20052:15 pmRNSDirector Shareholding
20th May 20059:28 amRNSHolding(s) in Company
13th May 20057:01 amRNSSystems integration partner
5th May 20056:27 pmRNSHolding(s) in Company
29th Apr 200511:45 amRNSHolding(s) in Company
28th Apr 20052:30 pmRNSResult of AGM
28th Apr 20057:00 amRNSPositive AGM update
25th Apr 20055:10 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.